Related Experiment Video
Updated: Sep 26, 2025

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
Published on: July 14, 2023
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
Pedro Caravaca Perez1,2, José R González-Juanatey1,3, Jorge Nuche1,4
1CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Insights
Galectin-3 (Gal-3) predicts mortality in acute heart failure (AHF) patients, but its prognostic value is significant only in those with renal dysfunction. Renal function impacts Gal-3 interpretation in AHF.
Area of Science:
- Cardiology
- Nephrology
- Biomarker Research
Background:
- Galectin-3 (Gal-3) is an inflammatory marker linked to heart failure (HF) progression.
- The interplay between Gal-3 and renal function in acute HF (AHF) requires further investigation.
Purpose of the Study:
- To assess the prognostic relationship between renal function and Gal-3 levels in patients hospitalized for AHF.
- To determine if renal function modifies the predictive value of Gal-3 for mortality.
Main Methods:
- An observational, prospective, multicenter registry of 1,201 AHF patients.
- Patients were stratified by estimated glomerular filtration rate (eGFR) into preserved (≥60 mL/min/1.73 m²) and impaired (<60 mL/min/1.73 m²) renal function groups.
- Cox regression analysis evaluated Gal-3 association with 12-month mortality, adjusting for eGFR and other variables.
Main Results:
- Gal-3 levels negatively correlated with eGFR (rho = -0.51, p < 0.001).
- Elevated Gal-3 was associated with higher 12-month mortality in multivariate analysis (HR = 1.010, p = 0.038).
- Prognostic value of Gal-3 was significant in patients with renal dysfunction (HR = 1.010, p = 0.033) but not in those with preserved renal function (HR = 0.990, p = 0.472).
Conclusions:
- Galectin-3 is a marker of increased mortality in AHF patients with renal dysfunction.
- Renal function significantly influences the prognostic utility of Gal-3 in AHF.
- eGFR adjustment is crucial for accurate interpretation of Gal-3 levels in AHF.
Introduction:
Galectin-3 (Gal-3) is an inflammatory marker associated with the development and progression of heart failure (HF). A close relationship between Gal-3 levels and renal function has been observed, but data on their interaction in patients with acute HF (AHF) are scarce. We aim to assess the prognostic relationship between renal function and Gal-3 during an AHF episode.
Materials And Methods:
This is an observational, prospective, multicenter registry of patients hospitalized for AHF. Patients were divided into two groups according to estimated glomerular filtration rate (eGFR): preserved renal function (eGFR ≥ 60 mL/min/1.73 m2) and renal dysfunction (eGFR <60 mL/min/1.73 m2). Cox regression analysis was performed to evaluate the association between Gal-3 and 12-month mortality.
Results:
We included 1,201 patients in whom Gal-3 values were assessed at admission. The median value of Gal-3 in our population was 23.2 ng/mL (17.3-32.1). Gal-3 showed a negative correlation with eGFR (rho = -0.51; p < 0.001). Gal-3 concentrations were associated with higher mortality risk in the multivariate analysis after adjusting for eGFR and other prognostic variables [HR = 1.010 (95%-CI: 1.001-1.018); p = 0.038]. However, the prognostic value of Gal-3 was restricted to patients with renal dysfunction [HR = 1.010 (95%-CI: 1.001-1.019), p = 0.033] with optimal cutoff point of 31.5 ng/mL, with no prognostic value in the group with preserved renal function [HR = 0.990 (95%-CI: 0.964-1.017); p = 0.472].
Conclusions:
Gal-3 is a marker of high mortality in patients with acute HF and renal dysfunction. Renal function influences the prognostic value of Gal-3 levels, which should be adjusted by eGFR for a correct interpretation.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

